ECSP066334A - Derivados bloqueadores del receptor angiotensina ii - Google Patents

Derivados bloqueadores del receptor angiotensina ii

Info

Publication number
ECSP066334A
ECSP066334A EC2006006334A ECSP066334A ECSP066334A EC SP066334 A ECSP066334 A EC SP066334A EC 2006006334 A EC2006006334 A EC 2006006334A EC SP066334 A ECSP066334 A EC SP066334A EC SP066334 A ECSP066334 A EC SP066334A
Authority
EC
Ecuador
Prior art keywords
angiotensin
derivatives
receptor blocker
receptor
blocker
Prior art date
Application number
EC2006006334A
Other languages
English (en)
Inventor
Nicoletta Almirante
Soldato Piero Del
Ennio Ongini
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of ECSP066334A publication Critical patent/ECSP066334A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a derivados bloqueadores del receptor angiotensina II (BRA).
EC2006006334A 2003-07-31 2006-01-30 Derivados bloqueadores del receptor angiotensina ii ECSP066334A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102379 2003-07-31

Publications (1)

Publication Number Publication Date
ECSP066334A true ECSP066334A (es) 2006-07-28

Family

ID=34112476

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006334A ECSP066334A (es) 2003-07-31 2006-01-30 Derivados bloqueadores del receptor angiotensina ii

Country Status (30)

Country Link
US (1) US20060276523A1 (es)
EP (1) EP1653950B1 (es)
JP (1) JP2007500684A (es)
KR (1) KR20060056352A (es)
CN (1) CN100496490C (es)
AR (1) AR045145A1 (es)
AT (1) ATE383155T1 (es)
AU (1) AU2004260830B2 (es)
BR (1) BRPI0413028A (es)
CA (1) CA2534451A1 (es)
CY (1) CY1110447T1 (es)
DE (1) DE602004011230T2 (es)
DK (1) DK1653950T3 (es)
EC (1) ECSP066334A (es)
ES (1) ES2299861T3 (es)
HK (1) HK1095093A1 (es)
HR (1) HRP20060084A2 (es)
IL (1) IL172703A0 (es)
IS (1) IS2534B (es)
MA (1) MA27987A1 (es)
MX (1) MXPA06001263A (es)
NO (1) NO20060900L (es)
NZ (1) NZ544463A (es)
PL (2) PL1653950T3 (es)
PT (1) PT1653950E (es)
RU (1) RU2374240C2 (es)
SI (1) SI1653950T1 (es)
UA (1) UA87983C2 (es)
WO (1) WO2005011646A2 (es)
ZA (1) ZA200600856B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006008196A1 (en) * 2004-07-20 2006-01-26 Nicox S.A. Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof
WO2006079610A1 (en) * 2005-01-31 2006-08-03 Nicox S.A. Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
CA2668744C (en) 2006-11-17 2015-09-15 Queen's University At Kingston Compounds and methods for treating protein folding disorders
ATE525371T1 (de) * 2006-12-06 2011-10-15 Shanghai Allist Pharmaceutical Inc Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davon
AU2007334521B2 (en) * 2006-12-13 2012-03-29 Merck & Co., Inc. Angiotensin II receptor antagonists
TW200831079A (en) * 2006-12-13 2008-08-01 Merck & Co Inc Angiotensin II receptor antagonists
CN101214242A (zh) 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
EP1980559A1 (en) * 2007-04-10 2008-10-15 CTG Pharma S.r.l. Cardiovascular agents
CN101317842A (zh) 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101407511B (zh) * 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物
AR069340A1 (es) * 2007-11-26 2010-01-13 Merck & Co Inc Antagonistas del receptor de angiotensina ii
EP2534957B1 (en) 2007-12-14 2015-05-27 AeroDesigns, Inc Delivering aerosolizable products
US7947664B2 (en) * 2008-01-24 2011-05-24 Merck Sharp & Dohme Corp. Angiotensin II receptor antagonists
CA2711461A1 (en) * 2008-02-08 2009-08-13 Merck Sharp & Dohme Corp. Angiotensin ii receptor antagonists
JP2011513268A (ja) * 2008-02-26 2011-04-28 ニコックス エス エイ アンジオテンシンｉｉ受容体アンタゴニスト
WO2009106471A2 (en) * 2008-02-26 2009-09-03 Nicox S.A. New angiotensin ii receptor blocker derivatives
CA2723725A1 (en) * 2008-05-15 2009-11-19 Merck Sharp & Dohme Corp. Angiotensin ii receptor antagonists
CN101596189A (zh) * 2008-06-05 2009-12-09 上海艾力斯生物医药有限公司 含有咪唑-5-羧酸类衍生物的药用组合物
CA2724919A1 (en) * 2008-06-09 2009-12-17 Nicox S.A. Angiotensin ii receptor antagonists
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
WO2010015447A1 (en) * 2008-08-08 2010-02-11 Nicox S.A. Angiotensin ii receptor antagonists
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
AR074425A1 (es) * 2008-12-05 2011-01-19 Merck Sharp & Dohme Derivados de nitrooxi como antagonistas del receptor de angiotensina ii.
MA33056B1 (fr) 2009-01-23 2012-02-01 Hanmi Holding Co Ltd Composition pharmaceutique solide comprenant de l'amlodipine et du losartan et son procede de fabrication
AR080925A1 (es) 2010-04-19 2012-05-16 Cardiolynx Ag Derivados de valsartan que portan donadores de no para el tratamiento de las enfermedades vasculares y metabolicas
WO2011132171A1 (en) * 2010-04-23 2011-10-27 Piramal Life Sciences Limited Nitric oxide releasing prodrugs of therapeutic agents
WO2011160974A2 (en) 2010-06-21 2011-12-29 Nicox S.A. Statin derivatives
JO3350B1 (ar) 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
WO2014111957A1 (en) 2013-01-21 2014-07-24 Apparao Satyam Nitric oxide releasing prodrugs of therapeutic agents
CN103275074B (zh) * 2013-06-21 2016-08-10 黄冈鲁班药业股份有限公司 一种奥美沙坦衍生物及其制备方法
CN105820125B (zh) * 2015-01-09 2018-12-07 北京中医药大学 一种用于治疗高血压的化合物及其制备方法和用途
CN108349911B (zh) 2015-09-07 2022-05-13 浙江华海药业股份有限公司 可释放一氧化氮的前药分子
CN106800537B (zh) * 2017-01-18 2019-02-01 广东隆赋药业股份有限公司 丁苯酞-替米沙坦杂合物及其制备方法和用途
CN108892624B (zh) * 2018-06-20 2020-12-15 重庆威鹏药业有限公司 沙库巴曲硝基氧衍生物及其制备方法和应用
CN114105881B (zh) * 2020-08-31 2024-01-26 沈阳海诺威医药科技有限公司 血小板聚集抑制剂及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0403159T3 (da) * 1989-06-14 2000-08-14 Smithkline Beecham Corp Imidazolylalkensyrer
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
WO2002015935A1 (fr) * 2000-08-25 2002-02-28 Takeda Chemical Industries, Ltd. Agents de reduction du fibrinogene
ITMI20011744A1 (it) * 2001-08-09 2003-02-09 Nicox Sa Farmaci per le vasculopatie

Also Published As

Publication number Publication date
JP2007500684A (ja) 2007-01-18
ATE383155T1 (de) 2008-01-15
ZA200600856B (en) 2007-05-30
UA87983C2 (ru) 2009-09-10
AU2004260830A1 (en) 2005-02-10
HRP20060084A2 (hr) 2006-04-30
RU2006105804A (ru) 2007-09-20
HK1095093A1 (en) 2007-04-27
US20060276523A1 (en) 2006-12-07
NO20060900L (no) 2006-02-24
IS8332A (is) 2006-02-27
DE602004011230D1 (de) 2008-02-21
WO2005011646A3 (en) 2005-04-21
CN100496490C (zh) 2009-06-10
PL1653950T3 (pl) 2008-08-29
KR20060056352A (ko) 2006-05-24
AR045145A1 (es) 2005-10-19
MA27987A1 (fr) 2006-07-03
IL172703A0 (en) 2006-04-10
DK1653950T3 (da) 2008-05-26
SI1653950T1 (sl) 2008-06-30
NZ544463A (en) 2009-10-30
PT1653950E (pt) 2008-04-11
ES2299861T3 (es) 2008-06-01
PL379420A1 (pl) 2006-09-04
DE602004011230T2 (de) 2009-01-02
IS2534B (is) 2009-08-15
AU2004260830B2 (en) 2010-04-29
MXPA06001263A (es) 2006-04-11
CN1832742A (zh) 2006-09-13
CA2534451A1 (en) 2005-02-10
BRPI0413028A (pt) 2006-10-03
EP1653950A2 (en) 2006-05-10
WO2005011646A2 (en) 2005-02-10
EP1653950B1 (en) 2008-01-09
RU2374240C2 (ru) 2009-11-27
CY1110447T1 (el) 2015-04-29

Similar Documents

Publication Publication Date Title
ECSP066334A (es) Derivados bloqueadores del receptor angiotensina ii
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
TW200717389A (en) Luminance adjustment
EA200801959A1 (ru) Высокоразветвленный полипропилен
NL1028584A1 (nl) Meerkanaals-oortelefoon.
NO20053549D0 (no) Fôringsmater.
CR9253A (es) Fijacion de la dosificacion de anticuerpos her
TNSN07264A1 (en) Organic compounds
BRPI0918472A2 (pt) composto 2,4-diaminopirimidina
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
IL176142A (en) Processes for preparing montelukast sodium
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
DK1506190T3 (da) (Imidazol-1-yl-methyl)-pyridazin som NMDA-receptor-blokker
SG149831A1 (en) Benzimidazole derivatives
TW200727908A (en) Herbal composition for treating cancer
SG138610A1 (en) Inhaler using pods
ATE456313T1 (de) Stirnband
CY1109038T1 (el) Μη στεροειδεις ρυθμιστες υποδοχεα γλυκοκορτικοειδων
SG129364A1 (en) Semiconductor device
FR2915660B1 (fr) Accessoire d'oreille, en particulier bijou d'oreille.
MX2008001269A (es) Sistema de higiene.
RU2012137206A (ru) Лигнангидроксилаза
HN2002000158A (es) Compuestos heterociclicos sustituidos con triamida
TR201915264U5 (tr) Pazar çantasi